Indication
Acute T-cell Leukemia
1 clinical trial
1 product
Clinical trial
The Safety and Clinical Efficacy of Human TRBC1 CAR-T Cell Therapy for Patients With Relapsed/Refractory TRBC1 Positive T Cell Hematological MaliganaciesStatus: , Estimated PCD: 2023-11-26
Product
Anti-TRBC1 CAR-T